We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Futura Medical Plc | LSE:FUM | London | Ordinary Share | GB0033278473 | ORD 0.2P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.45 | 1.27% | 36.00 | 35.80 | 36.45 | 36.50 | 36.00 | 36.50 | 18,940 | 08:42:02 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 0 | -5.85M | -0.0194 | -18.32 | 106.9M |
From Apr 2019 to Apr 2024
TIDMFUM
RNS Number : 7723H
Futura Medical PLC
19 November 2018
Directors' / PDMR Dealing and Grant of Options
19 November 2018
Futura Medical plc (AIM: FUM) (the "Company"), a pharmaceutical company developing a portfolio of innovative products for sexual health and pain relief, today announces that on 19 November 2018 it made its annual grant of options over a total of 1,340,000 ordinary shares of 0.2p each in the Company ("Ordinary Shares") to employees and Directors, of which 650,000 options were granted to Directors and PDMRs as detailed below.
Hot Features
Premium
Total number
Number of options Total number
of options Exercise held following of Ordinary
Director granted price Exercise period notification Shares held
1 Oct 2020 - 30
J H Barder 250,000 7.5p Sep 2025 1,500,000 1,835,972
1 Oct 2020 - 30
A Hildreth 200,000 7.5p Sep 2025 200,000 142,857
1 Oct 2020 - 30
K W James 200,000 7.5p Sep 2025 600,000 299,581
The 1,340,000 options granted were granted under the Futura Medical plc Enterprise Management Incentive Scheme.
The main vesting condition of the options is that the Director/PDMR/employee remains employed with the Company as at the date of exercise. Further disclosures are contained in the tables below.
For further information please contact:
Futura Medical plc
James Barder, Chief Executive
Angela Hildreth, Finance Director and COO
Email: Investor.relations@futuramedical.com
Tel: +44 (0) 1483 685 670
Nominated Adviser and Broker:
N+1 Singer
Aubrey Powell/ Ben Farrow (Corporate Finance)
Tom Salvesen/ Mia Gardner (Corporate Broking)
Tel: +44 (0) 20 7496 3000
For media enquiries please contact:
Optimum Strategic Communications
Mary Clark/ Hollie Vile/ Ellie Blackwell
Email: futuramedical@optimumcomms.com
Tel: +44 (0) 203 950 9144
Notes to editors
About Futura Medical plc
Futura Medical plc (AIM: FUM), is a pharmaceutical company developing a portfolio of innovative products based on its proprietary, transdermal DermaSys(R) drug delivery technology. These products are optimised for clinical efficacy, safety, administration and patient convenience and are developed for the prescription and consumer healthcare markets as appropriate. Current therapeutic areas are sexual health, including erectile dysfunction, and pain relief. Development and commercialisation strategies are designed to maximise product differentiation and value creation whilst minimising risk.
Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange. www.futuramedical.com
1 Details of the person discharging managerial responsibilities/person
closely associated
a) Name James Barder
----------------------------------------- -------------------------------
2 Reason for the notification
--------------------------------------------------------------------------
a) Position/status Chief Executive Officer
----------------------------------------- -------------------------------
b) Initial notification/Amendment Initial notification
----------------------------------------- -------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
--------------------------------------------------------------------------
a) Name Futura Medical plc
----------------------------------------- -------------------------------
b) LEI 21380053QLT46UNV2303
----------------------------------------- -------------------------------
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
--------------------------------------------------------------------------
a) Description of the financial instrument, Ordinary Shares of 0.2 pence
type of instrument each
Identification code
GB0033278473
----------------------------------------- -------------------------------
b) Nature of the transaction Issue of options over Ordinary
Shares
----------------------------------------- -------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
Exercise price
of
7.5 pence 250,000
----------
----------------------------------------- -------------------------------
d) Aggregated information N/A single transaction
- Aggregated volume
- Price
----------------------------------------- -------------------------------
e) Date of the transaction 19 November 2018
----------------------------------------- -------------------------------
f) Place of the transaction Outside a trading venue
----------------------------------------- -------------------------------
1 Details of the person discharging managerial responsibilities/person
closely associated
a) Name Angela Hildreth
----------------------------------------- -------------------------------
2 Reason for the notification
--------------------------------------------------------------------------
a) Position/status Finance Director and
Chief Operating Officer
----------------------------------------- -------------------------------
b) Initial notification/Amendment Initial notification
----------------------------------------- -------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
--------------------------------------------------------------------------
a) Name Futura Medical plc
----------------------------------------- -------------------------------
b) LEI 21380053QLT46UNV2303
----------------------------------------- -------------------------------
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
--------------------------------------------------------------------------
a) Description of the financial instrument, Ordinary Shares of 0.2 pence
type of instrument each
Identification code
GB0033278473
----------------------------------------- -------------------------------
b) Nature of the transaction Issue of options over Ordinary
Shares
----------------------------------------- -------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
Exercise price
of
7.5 pence 200,000
----------
----------------------------------------- -------------------------------
d) Aggregated information N/A single transaction
- Aggregated volume
- Price
----------------------------------------- -------------------------------
e) Date of the transaction 19 November 2018
----------------------------------------- -------------------------------
f) Place of the transaction Outside a trading venue
----------------------------------------- -------------------------------
1 Details of the person discharging managerial responsibilities/person
closely associated
a) Name Ken James
----------------------------------------- -------------------------------
2 Reason for the notification
--------------------------------------------------------------------------
a) Position/status Executive Director
and Head of R&D
----------------------------------------- -------------------------------
b) Initial notification/Amendment Initial notification
----------------------------------------- -------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
--------------------------------------------------------------------------
a) Name Futura Medical plc
----------------------------------------- -------------------------------
b) LEI 21380053QLT46UNV2303
----------------------------------------- -------------------------------
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
--------------------------------------------------------------------------
a) Description of the financial instrument, Ordinary Shares of 0.2 pence
type of instrument each
Identification code
GB0033278473
----------------------------------------- -------------------------------
b) Nature of the transaction Issue of options over Ordinary
Shares
----------------------------------------- -------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
Exercise price
of
7.5 pence 200,000
----------
----------------------------------------- -------------------------------
d) Aggregated information N/A single transaction
- Aggregated volume
- Price
----------------------------------------- -------------------------------
e) Date of the transaction 19 November 2018
----------------------------------------- -------------------------------
f) Place of the transaction Outside a trading venue
----------------------------------------- -------------------------------
ENDS
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
DSHLLFILLFLALIT
(END) Dow Jones Newswires
November 19, 2018 06:03 ET (11:03 GMT)
1 Year Futura Medical Chart |
1 Month Futura Medical Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
